Global Congress on Prostate Cancer - PROSCA 2019

prosca.org

 

CRPC in Clinical Practice
19:14

Global Congress on Prostate Cancer - PROSCA 2019

To Treat or Not to Treat Non-Metastatic Castration Resistant Prostate Cancer: Effectiveness and Safety Profile of Darolutamide, Enzalutamide, and Apalutamide

FEATURING Karim Fizazi
  • 273 views
  • December 31, 2019
20:43

Global Congress on Prostate Cancer - PROSCA 2019

Early Enzalutamide, Apalutamide, or Abiraterone Are the New Standard Treatment of Early Asymptomatic mCRPC / Rapidly Progression nmCRPC

FEATURING Bertrand Tombal
  • 762 views
  • January 7, 2020
  • 5
21:24

Global Congress on Prostate Cancer - PROSCA 2019

New Agents in mCRPC: PARPi Should Have Role for DDR-Deficient Disease

FEATURING Petros Grivas
  • 138 views
  • January 10, 2020